院内院内心脏骤停后的长期功能结局与健康相关生活质量:系统评价
该研究为按PRISMA 2020开展的系统评价与Meta分析,纳入21个国家39项研究,成人(≥18岁)院内院内心脏骤停接受传统心肺复苏且报告≥3个月神经、认知、心理或健康相关生活质量结局。全队列不良神经结局汇总比例为78.9%(95%CI 73.5-83.4%),幸存者中为9.9%(95%CI 5.8-16.3%),随访越长比例越低;幸存者临床显著焦虑13.1%、抑郁8.1%。健康相关生活质量损害常见于疼痛/不适60.5%、日常活动52.6%、焦虑/抑郁49.0%。多数分析异质性高(I2>75%),结局测量与随访时长差异大使合并受限,作者认为需标准化结局测量与报告以指导骤停后照护。
要点
- 院内心脏骤停全队列不良神经结局汇总比例78.9%(95%CI 73.5-83.4%;I2=95.6%),幸存者中仅9.9%(95%CI 5.8-16.3%),随访越长比例越低。
- 幸存者临床显著焦虑13.1%(95%CI 6.1-26.0%)、抑郁8.1%(95%CI 4.6-13.7%)。
- 幸存者健康相关生活质量损害以疼痛/不适60.5%、日常活动52.6%、焦虑/抑郁49.0%最常见。
- 多数分析异质性I2>75%,结局测量与随访时长差异大限制合并,作者认为需标准化结局测量与报告。
适用人群与场景
- 成人(≥18岁)院内院内心脏骤停并接受传统心肺复苏者。
- 纳入条件为报告骤停后≥3个月的神经、认知、心理或健康相关生活质量结局。
- 共纳入21个国家39项研究,样本量n=16-1539例患者。
研究设计与关键结果
- 系统评价与Meta分析,检索MEDLINE、EMBASE、CINAHL、CENTRAL、PEDro至2025年2月14日,纳入21个国家39项研究(样本量n=16-1539例)。
- 全队列不良神经结局汇总比例78.9%(95%CI 73.5-83.4%;I2=95.6%)。
- 幸存者中不良神经结局9.9%(95%CI 5.8-16.3%;I2=86.4%),随访越长比例越低。
- 幸存者临床显著焦虑13.1%(95%CI 6.1-26.0%;I2=92.3%)、抑郁8.1%(95%CI 4.6-13.7%;I2=75.7%)。
- 健康相关生活质量损害:疼痛/不适60.5%(95%CI 57.9-63.0%;I2=37.6%)、日常活动52.6%(95%CI 50.0-55.2%;I2=0.0%)、焦虑/抑郁49.0%(95%CI 46.4-51.6%;I2=0.0%)。
- 认知损害仅一项研究报告。
证据类型、等级与局限
- 证据类型:按PRISMA 2020开展的系统评价与Meta分析,采用QUIPS工具评估偏倚风险,方案注册于PROSPERO(CRD420251009496)。
- 多数纳入研究为中等至高度偏倚风险。
- 多数分析存在显著统计学异质性(I2>75%)。
- 局限:结局测量指标、随访时长和报告方法差异大,限制了结果的合并。
对床旁实践的改变
- 作者认为需提高结局测量与报告的标准化,以改善研究间可比性并指导骤停后照护。
- 幸存者中不良神经结局比例随随访延长而降低,幸存者焦虑、抑郁及疼痛/不适等健康相关生活质量损害常见。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: To evaluate long-term functional outcomes following in-hospital cardiac arrest (IHCA).
METHODS: A systematic review and meta-analysis were conducted in accordance with PRISMA 2020 guidelines. MEDLINE, EMBASE, CINAHL, CENTRAL, and PEDro were searched to 14 February 2025. Eligible studies included adults (≥18 years) who received conventional cardiopulmonary resuscitation for IHCA and reported neurological, cognitive, psychological, or health-related quality of life (HRQoL) outcomes at ≥ 3 months post-IHCA. Risk of bias was assessed using the QUIPS tool. Meta-analyses of binary outcomes were performed using random-intercept logistic regression. Narrative synthesis was used where pooling of results was not feasible. The protocol was registered with PROSPERO (CRD420251009496).
RESULTS: Thirty-nine studies from 21 countries were included (sample size n = 16-1539 patients). Most were moderate to high risk of bias. Across the full cohort, the pooled proportion of poor neurological outcome was 78.9% (95% CI 73.5-83.4%; I2 = 95.6%). Among survivors, 9.9% (95% CI 5.8-16.3%; I2 86.4%) had poor neurological outcome, with lower proportions at longer follow-up. Clinically significant anxiety and depression affected 13.1% (95% CI 6.1-26.0%; I2 = 92.3%) and 8.1% (95% CI 4.6-13.7%; I2 = 75.7%) of survivors, respectively. HRQoL impairments were frequently reported, particularly in pain/discomfort (60.5% [95% CI 57.9-63.0%; I2 = 37.6%]), usual activities (52.6% [95% CI 50.0-55.2%; I2 = 0.0%]), and anxiety/depression (49.0% [95% CI 46.4-51.6%; I2 = 0.0%]). Cognitive impairments were reported in one study. Substantial statistical heterogeneity (I2 > 75%) was observed across most analyses. Wide variation in outcome measures, follow-up duration, and reporting methods limited synthesis.
CONCLUSION: While many IHCA survivors achieve favourable long-term outcomes, a significant proportion experience persistent impairments. Greater standardisation in outcome measurement and reporting is needed to improve comparability across studies and guide post-arrest care.
参考来源
- Pound GM, Grimwood C, Rix A, et al. Long-term functional outcomes and health-related quality of life following in-hospital cardiac arrest (IHCA): A systematic review. Resuscitation. 2025. PMID: 40499674. doi:10.1016/j.resuscitation.2025.110673
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。